News
16h
Zacks.com on MSNShould You Buy, Hold, or Sell BMY Stock Ahead of Q2 Earnings?Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
4d
Zacks.com on MSNHas BioNTech (BNTX) Outpaced Other Medical Stocks This Year?Here is how BioNTech SE Sponsored ADR (BNTX) and EUROFINS SCIENT (ERFSF) have performed compared to their sector so far this year.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that the European Medicines Agency's (EMA) Committee for ...
The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...
Review the current BioNTech SE ADR (BNTX:XNAS) dividend yield and history to decide if BNTX is the best investment for you.
5d
Zacks.com on MSNHere's What to Expect From Pfizer's Non-Oncology Drugs in Q2 EarningsPFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...
Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...
The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results